Value of Information

Raiffa H Schlaiffer R . Applied Statistical Decision Theory. Wiley Classics Library, ed. New York: Wiley Interscience; 2000.

Ades AE Lu G Claxton K . Expected value of sample information calculations in medical decision modeling. Medical Decis Making. 2004;24:207–27.

Madan J Ades AE Price M . Strategies for efficient computation of the expected value of partial perfect information. Medical Decis Making. 2014;34(3):327–42.

Welton NJ Madan JJ Caldwell DM Peters TJ Ades AE . Expected value of sample information for cluster randomised trials with binary outcomes. Medical Decis Making. 2014;34:352–65.

Tappenden P Chilcott J Eggington S Oakley J McCabe C . Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-β and glatiramer acetate for multiple sclerosis. Health Technol Assess. 2004;8(27):iii, 1–78.

Stevenson MD Oakley J Chilcott JB . Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis. Med Decis Making. 2004;24(1):89–100.

Strong M Oakley JE Brennan A Breeze P . Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast non-parametric regression-based method. Med Decis Making. 2015;35:570–583.

Jalal H Goldhaber-Fiebert JD Kuntz KM . Computing expected value of partial sample information from probabilistic sensitivity analysis using linear regression metamodeling. Medical Decis Making. 2015;35:584–595.

Ades AE Sculpher M Sutton A . Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics. 2006;24(1):1–19.

Welton NJ Sutton AJ Cooper NJ Abrams KR Ades AE . Evidence Synthesis for Decision Making in Healthcare. New York: Wiley; 2012.

Dias S Sutton AJ Ades AE Welton NJ . Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Medical Decis Making. 2013;33:607–17.

Conti S Claxton K . Dimensions of design space: a decision-theoretic approach to optimal research design. Medical Decis Making. 2009;29:643–60.

Price MJ Welton NJ Ades AE . Model averaging in the presence of structural uncertainty about treatment effects: impact on treatment decision and expected value of information. Value Health. 2011;14(2):205–218.

Bojke L Claxton K Sculpher M Palmer S . Characterizing structural uncertainty in decision analytic models: a review and application of methods. Value Health. 2009;12:739–49.

Jackson CH Sharples LD Thompson SG . Structural and parameter uncertainty in Bayesian cost-effectiveness models. J R Stat Soc Ser C Appl Stat. 2010;59:233–53.

Jackson CH Thompson SG Sharples LD . Accounting for uncertainty in health economic decision models by using model averaging. J R Stat Soc Ser A Stat Soc. 2009;172:383–404.

Thom H . Structural Uncertainty in Cost-Effectiveness Models [doctoral dissertation]. Cambridge (UK): University of Cambridge; 2013.

Strong M . Managing Structural Uncertainty in Health Economic Decision Models [PhD dissertation]. Sheffield (UK): University of Sheffield; 2012.

Baio G . Bayesian Methods in Health Economics. Boca Raton, FL: Chapman & Hall/CRC Press; 2013.

Claxton KP Sculpher MJ . Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics. 2006;24(11):1055–68.

Colbourn TE Asseburg C Bojke L . Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ. 2007;335:655–61.

Soares M Welton NJ Harrison DA . An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess. 2012;16(7):1–186.

Claxton K Palmer S Longworth L . Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technol Assess. 2012;16(46):1–323.